Literature DB >> 27651663

"The Jelly Belly": Diagnostic Dilemmas and Current Concepts.

Priyanka Punit Kedia1, Gayatri Ravikumar1, Suravi Mohanty1, Julian Crasta1, Elizabeth Vallikad2.   

Abstract

BACKGROUND: Pseudomyxoma peritonei (PMP) is a rare and poorly understood clinicopathological entity characterized by gelatinous ascites with neoplastic or non-neoplastic mucinous implants in the peritoneum. Although its origin was debated, current evidence in literature favours the appendix as the origin of the disease, over the ovaries. The changing terminologies in the classification of this entity pose diagnostic and management challenges. CASE REPORTS: Herein, we report three cases of PMP in postmenopausal women, their clinical presentation, pathological staging based on the peritoneal tumor deposits and the treatment administered. Two patients recovered uneventfully, while one had recurrence of adenocarcinoma.
CONCLUSION: The rarity of this disease and the diagnostic challenges associated with it are discussed with an emphasis on the current concepts in its origin and management. Appropriate classification and complete removal of the tumor is mandated to prevent disease-related mortality.

Entities:  

Keywords:  Classification; Diagnosis; Management; Origin; Pseudomyxoma peritonei

Year:  2016        PMID: 27651663      PMCID: PMC5016483          DOI: 10.1007/s13224-016-0921-z

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  16 in total

Review 1.  Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei.

Authors:  Joseph Misdraji
Journal:  Mod Pathol       Date:  2015-01       Impact factor: 7.842

Review 2.  Current status and future directions in appendiceal cancer with peritoneal dissemination.

Authors:  Konstantinos I Votanopoulos; Perry Shen; John H Stewart; Edward A Levine
Journal:  Surg Oncol Clin N Am       Date:  2012-10       Impact factor: 3.495

3.  Unusual origins of Pseudomyxoma peritonei.

Authors:  E de Bree; A Witkamp; M Van De Vijver; F Zoetmulde
Journal:  J Surg Oncol       Date:  2000-12       Impact factor: 3.454

Review 4.  Pseudomyxoma peritonei.

Authors:  R Harshen; R Jyothirmayi; N Mithal
Journal:  Clin Oncol (R Coll Radiol)       Date:  2003-04       Impact factor: 4.126

5.  Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women.

Authors:  B M Ronnett; B M Shmookler; M Diener-West; P H Sugarbaker; R J Kurman
Journal:  Int J Gynecol Pathol       Date:  1997-01       Impact factor: 2.762

Review 6.  Mucinous neoplasms of the appendix and peritoneum.

Authors:  Nicole C Panarelli; Rhonda K Yantiss
Journal:  Arch Pathol Lab Med       Date:  2011-10       Impact factor: 5.534

Review 7.  Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis.

Authors:  Katherine McBride; David McFadden; Turner Osler
Journal:  J Surg Res       Date:  2013-01-10       Impact factor: 2.192

8.  Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.

Authors:  B M Ronnett; R J Kurman; C M Zahn; B M Shmookler; K A Jablonski; M E Kass; P H Sugarbaker
Journal:  Hum Pathol       Date:  1995-05       Impact factor: 3.466

9.  MUC2 is a molecular marker for pseudomyxoma peritonei.

Authors:  Jerome T O'Connell; Cammy M Hacker; Sanford H Barsky
Journal:  Mod Pathol       Date:  2002-09       Impact factor: 7.842

10.  Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.

Authors:  Rei Noguchi; Hideaki Yano; Yoshimasa Gohda; Ryuichiro Suda; Toru Igari; Yasunori Ohta; Naohide Yamashita; Kiyoshi Yamaguchi; Yumi Terakado; Tsuneo Ikenoue; Yoichi Furukawa
Journal:  Cancer Med       Date:  2015-10-16       Impact factor: 4.452

View more
  1 in total

1.  Jelly from the belly button: What's the diagnosis?

Authors:  Herbert L Fred; Gabriel M Aisenberg; Agnes M Guthrie; Hendrik A van Dijk
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.